Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

15.46 -0.05 (-0.32%)
Official Closing Price Updated: 7:00 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 63,952,576
Open 14.83
Bid (Size) 15.39 (36,700)
Ask (Size) 15.41 (1,200)
Prev. Close 15.51
Today's Range 13.74 - 16.06
52wk Range 13.74 - 70.43
Shares Outstanding 191,922,517
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
HIMS Stock Plummets After Wall Street Downgrade, Price Target Cuts Following 'Disappointing' Q4 Report ↗
HIMS stock is currently trading at levels last seen in September 2024 and has fallen over 50% year-to-date. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Hims & Hers Health (HIMS): Decoding the Q4 Earnings Beat vs. the SEC GLP-1 Investigation
As of February 24, 2026, the market narrative surrounding Hims & Hers Health (NYSE: HIMS) has become a stark "tale of two tapes." On one hand, the digital health disruptor recently reported a robust Q4... 
Via Finterra
Topics Earnings Economy Initial Public Offering

Performance

YTD
-53.7%
-53.7%
1 Month
-48.9%
-48.9%
3 Month
-59.1%
-59.1%
6 Month
-64.0%
-64.0%
1 Year
-69.9%
-69.9%

More News

Read More
News headline image
Nasdaq, S&P 500 Futures Steady After AI Fears Roil Tech: Why IBM, NVDA, NFLX, HIMS, PFE Are On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence ETFs Government
Hims & Hers Health Inc (NYSE:HIMS) Stock Falls on Weak Q1 2026 Revenue Guidance Despite Q4 Earnings Beat ↗
Via Chartmill
HIMS Stock Plunges 8 Straight Days: Is The GLP-1 Fallout Already Priced In? ↗
Via Stocktwits
News headline image
HIMS Stock Slumps Nearly 10% After-Hours: How CEO Dudum Plans To Offset GLP-1 Risk ↗
Via Stocktwits
Topics Earnings
News headline image
Hims & Hers (HIMS) Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Hims & Hers Health Reports Mixed Q4 Earnings, Subscribers Cross 2.5 Million ↗
Via Benzinga
News headline image
Hims & Hers Health’s (NYSE:HIMS) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Via StockStory
News headline image
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
From Hims & Hers
Via Business Wire
News headline image
High Volatility and Earnings Crossroads: A Deep Dive into Hims & Hers Health (HIMS) in 2026
Via Finterra
Topics Artificial Intelligence Intellectual Property Lawsuit
News headline image
HIMS Stock Short Interest At Record Levels Ahead Of Q4 Earnings: What Are Bears Betting Against? ↗
Via Stocktwits
News headline image
What To Expect From Hims & Hers Health’s (HIMS) Q4 Earnings
Via StockStory
Topics Artificial Intelligence Economy World Trade
News headline image
Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside ↗
Via MarketBeat
News headline image
Hims & Hers HUGE Acquisition News! ↗
Via The Motley Fool
News headline image
Hims & Hers Health Makes Australia, Japan Foray With $1.15 Billion Eucalyptus Acquisition ↗
Via Stocktwits
News headline image
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
From Hims & Hers
Via Business Wire
News headline image
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
2 Profitable Stocks on Our Watchlist and 1 We Ignore
Via StockStory
News headline image
Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know
Via StockStory
Topics Economy
News headline image
Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial ↗
Via Stocktwits
News headline image
The Vertical Integration of Wellness: A Deep Dive into Hims & Hers Health (HIMS)
Via Finterra
Topics Artificial Intelligence Intellectual Property Lawsuit
News headline image
Stocks making big moves yesterday: Shopify, Snowflake, Ryan Specialty, Merchants Bancorp, and Hims & Hers Health
Via StockStory
Topics Stocks
Dow 50,000 is No Longer a Mirage, but the "Accounting Ghost" Haunts Tech ↗
Via Chartmill
Topics Stocks
News headline image
Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit ↗
Via The Motley Fool
Topics Artificial Intelligence Lawsuit Stocks

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?
Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.
What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?
Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?
The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange
What is the current price of Hims & Hers Health, Inc. Class A Common Stock?
The current price of Hims & Hers Health, Inc. Class A Common Stock is 15.46
When was Hims & Hers Health, Inc. Class A Common Stock last traded?
The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 02/24/26 07:00 PM ET
What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?
The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 2.97B
How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?
Hims & Hers Health, Inc. Class A Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.